Words of wisdom. Re: feasibility of the use of phosphodiesterase type 5 inhibitors in a pharmacologic prevention program for recurrent priapism
Saved in:
| Published in | European urology Vol. 52; no. 3; pp. 918 - 919 |
|---|---|
| Main Authors | , |
| Format | Journal Article |
| Language | English |
| Published |
Switzerland
01.09.2007
|
| Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!